Divya A. Khandekar

Highly skilled hematology oncology clinical pharmacist with 8 years of patient care and clinical research experience. Demonstrates a comprehensive understanding of hematologic malignancies, with deep expertise in lymphoma, multiple myeloma, and the clinical integration of novel therapies, including bispecific T-cell engagers and antibody-drug conjugates, along with strong formulary and P&T leadership. Partners with multidisciplinary and industry stakeholders to translate emerging clinical data into practice, lead quality initiatives, and optimize complex treatment strategies.

• Primary preceptor, Inpatient lymphoma/myeloma services for all PGY1 and PGY2 (Oncology) pharmacy residents, 08/01/24 to Present
• Co-preceptor, Inpatient solid tumor service, 08/01/24 to Present
• Co-preceptor, Hematology/oncology research and QI projects
• Guest lecturer, Oncologic emergencies at Roosevelt University, 06/01/24 & 06/01/25
• Guest lecturer, Pharmacotherapeutics of Multiple Myeloma at Midwestern University College of Pharmacy, 07/01/24 & 07/01/25

• Hematology Oncology Pharmacist Association (HOPA) : provide write commentary on clinical guideline updates in Oncology Pulse Point: Pharmacist Insights in collaboration with Pharmacy Times. Also involved review of BCOP recertification content review and contribute to HOPA news as needed. HOPANews_Vol22_Issue4-v4-4web.pdf
• Oncology Pharmacy Network (OPN) : Board member. Involved in planning of yearly conference including selecting speakers and managing day of logistics.
• Multiple Myeloma Grand Rounds Chicago : Will be involved as a speaker representing Northwestern memorial hospital in 2026

• CPDG Alumni Service Award, Midwestern University Chicago College of Pharmacy, 11/01/25
• Finalist-Outstanding PGY1 Resident Research Award, Minnesota Society of Health-System Pharmacists, 03/01/22
• Outstanding Presentation Award, Kenneth Suarez Research Day Midwestern University, 01/01/19
• Silver Snapshot Award, Abstract submitted to SCCM 2019 Critical Care Congress, 01/01/19
• The Albert Schweitzer Fellowship-Chicago, 01/01/19

• Enterprise standardization and convergence of large-volume infusion pump drug libraries., Am J Health Syst Pharm., 12/01/23, 80, 23, 1743-1751
• Intraoperative Versus Postoperative Hydroxocobalamin for Vasoplegic Shock in Cardiothoracic Surgery., J Cardiothorac Vasc Anesth., 12/01/23, 37, 12, 2538-2545
• Sovateltide (IRL-1620) affects neuronal progenitors and prevents cerebral tissue damage after ischemic stroke., Can J Physio Pharmacol., 09/01/20, 98, 9, 659-666
• Endothelin-B receptor stimulation by IRL-1620 induces NeuroD1 mediated neurogenesis after stroke., Crit Care Med., 01/01/19, 47, 1, 772

• Development of a platinum desensitization guideline, Vizient Pharmacy Network Meeting, Las Vegas, 12/01/22
• Early Hydroxocobalamin for vasoplegic shock in cardiothoracic surgery., NorthStar conference, Minneapolis, 05/01/22
• Enterprise large volume infusion pump drug library standardization, Vizient Pharmacy Network Meeting, 12/01/21
• Factors associated with over-sedation following intubation, ASHP Midyear Conference, Las Vegas, 01/01/19
• Factors associated with hemodynamic instability following intubation, ASHP Midyear Conference, Las Vegas, 01/01/19
• Effect of Endothelin-B receptor simulation on neurogenesis markers in rat brain following stroke, ACCP Global Conference, Seattle, 10/01/18